Abstract
Lung cancer is the leading cause of cancer deaths worldwide with non small-cell lung cancer (NSCLC) accounting for 80% of all lung cancers. Although activating mutations in genes of the RAS-MAPK pathway occur in up to 30% of all NSCLC, the cooperating genetic lesions that are required for lung cancer initiation and progression remain poorly understood. Here we identify a role for the cell polarity regulator Scribble (Scrib) in NSCLC. A survey of genomic databases reveals deregulation of SCRIB in human lung cancer and we show that Scrib+/− mutant mice develop lung cancer by 540 days with a penetrance of 43%. To model NSCLC development in vivo, we used the extensively characterized LSL-KRasG12D murine model of NSCLC. We show that loss of Scrib and activated oncogenic KRas cooperate in vivo, resulting in more aggressive lung tumors, likely due to a synergistic elevation in RAS–MAPK signaling. Finally, we provide data consistent with immune infiltration having an important role in the acceleration of tumorigenesis in KRasG12D lung tumors following Scrib loss.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Travis WD . Pathology of lung cancer. Clin Chest Med 2002; 23: 65–81 viii.
Meuwissen R, Berns A . Mouse models for human lung cancer. Genes Dev 2005; 19: 643–664.
Fisher GH, Wellen SL, Klimstra D, Lenczowski JM, Tichelaar JW, Lizak MJ et al. Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. Genes Dev 2001; 15: 3249–3262.
Jackson EL, Olive KP, Tuveson DA, Bronson R, Crowley D, Brown M et al. The differential effects of mutant p53 alleles on advanced murine lung cancer. Cancer Res 2005; 65: 10280–10288.
Ji H, Ramsey MR, Hayes DN, Fan C, McNamara K, Kozlowski P et al. LKB1 modulates lung cancer differentiation and metastasis. Nature 2007; 448: 807–810.
Bilder D, Li M, Perrimon N . Cooperative regulation of cell polarity and growth by Drosophila tumor suppressors. Science 2000; 289: 113–116.
Bryant PJ, Huwe A . LAP proteins: what's up with epithelia? Nat Cell Biol 2000; 2: E141–E143.
Gardiol D, Zacchi A, Petrera F, Stanta G, Banks L . Human discs large and scrib are localized at the same regions in colon mucosa and changes in their expression patterns are correlated with loss of tissue architecture during malignant progression. Int J Cancer 2006; 119: 1285–1290.
Kamei Y, Kito K, Takeuchi T, Imai Y, Murase R, Ueda N et al. Human scribble accumulates in colorectal neoplasia in association with an altered distribution of beta-catenin. Hum Pathol 2007; 38: 1273–1281.
Navarro C, Nola S, Audebert S, Santoni MJ, Arsanto JP, Ginestier C et al. Junctional recruitment of mammalian Scribble relies on E-cadherin engagement. Oncogene 2005; 24: 4330–4339.
Ouyang Z, Zhan W, Dan L . hScrib a human homolog of Drosophila neoplastic tumor suppressor, is involved in the progress of endometrial cancer. Oncol Res 2010; 18: 593–599.
Vaira V, Faversani A, Dohi T, Maggioni M, Nosotti M, Tosi D et al. Aberrant overexpression of the cell polarity module scribble in human cancer. Am J Pathol 2011; 178: 2478–2483.
Zhan L, Rosenberg A, Bergami KC, Yu M, Xuan Z, Jaffe AB et al. Deregulation of scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinoma. Cell 2008; 135: 865–878.
Pearson HB, Perez-Mancera PA, Dow LE, Ryan A, Tennstedt P, Bogani D et al. SCRIB expression is deregulated in human prostate cancer, and its deficiency in mice promotes prostate neoplasia. J Clin Invest 2011; 121: 4257–4267.
Huang L, Muthuswamy SK . Polarity protein alterations in carcinoma: a focus on emerging roles for polarity regulators. Curr Opin Genet Dev 2010; 20: 41–50.
Muthuswamy SK, Xue B . Cell polarity as a regulator of cancer cell behavior plasticity. Annu Rev Cell Dev Biol 2012; 28: 599–625.
Martin-Belmonte F, Perez-Moreno M . Epithelial cell polarity, stem cells and cancer. Nat Rev Cancer 2012; 12: 23–38.
Humbert PO, Grzeschik NA, Brumby AM, Galea R, Elsum I, Richardson HE . Control of tumourigenesis by the Scribble/Dlg/Lgl polarity module. Oncogene 2008; 27: 6888–6907.
Elsum I, Yates L, Humbert PO, Richardson HE . The Scribble-Dlg-Lgl polarity module in development and cancer: from flies to man. Essays Biochem 2012; 53: 141–168.
Brumby AM, Richardson HE . scribble mutants cooperate with oncogenic Ras or Notch to cause neoplastic overgrowth in Drosophila. Embo J 2003 3 22: 5769–5779.
Pagliarini RA, Xu T . A genetic screen in Drosophila for metastatic behavior. Science 2003; 302: 1227–1231.
Dow LE, Elsum IA, King CL, Kinross KM, Richardson HE, Humbert PO . Loss of human Scribble cooperates with H-Ras to promote cell invasion through deregulation of MAPK signalling. Oncogene 2008; 27: 5988–6001.
DuPage M, Dooley AL, Jacks T . Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase. Nat Protoc 2009; 4: 1064–1072.
Jackson EL, Willis N, Mercer K, Bronson RT, Crowley D, Montoya R et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 2001; 15: 3243–3248.
Fulda S . Tumor resistance to apoptosis. Int J Cancer 2009; 124: 511–515.
Ramakrishna G, Bialkowska A, Perella C, Birely L, Fornwald LW, Diwan BA et al. Ki-ras and the characteristics of mouse lung tumors. Mol Carcinog 2000; 28: 156–167.
Zhou Y, Rideout WM 3rd, Zi T, Bressel A, Reddypalli S, Rancourt R et al. Chimeric mouse tumor models reveal differences in pathway activation between ERBB family- and KRAS-dependent lung adenocarcinomas. Nat Biotechnol 2010; 28: 71–78.
Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, Vogel S et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005; 121: 823–835.
Onder TT, Gupta PB, Mani SA, Yang J, Lander ES, Weinberg RA. . Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 2008; 68: 3645–3654.
Chatterjee S, Seifried L, Feigin ME, Gibbons DL, Scuoppo C, Lin W et al. Dysregulation of cell polarity proteins synergize with oncogenes or the microenvironment to induce invasive behavior in epithelial cells. PLoS One 2012; 7: e34343.
Pages F, Galon J, Dieu-Nosjean MC, Tartour E, Sautes-Fridman C, Fridman WH. . Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene 2010; 29: 1093–1102.
Sica A, Allavena P, Mantovani A . Cancer related inflammation: the macrophage connection. Cancer Lett 2008; 267: 204–215.
Ji H, Houghton AM, Mariani TJ, Perera S, Kim CB, Padera R et al. K-ras activation generates an inflammatory response in lung tumors. Oncogene 2006; 25: 2105–2112.
Hao NB, Lu MH, Fan YH, Cao YL, Zhang ZR, Yang SM . Macrophages in tumor microenvironments and the progression of tumors. Clin Dev Immunol 2012; 2012: 948098.
Mantovani A, Sozzani S, Locati M, Allavena P, Sica A . Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002; 23: 549–555.
Martinez FO, Sica A, Mantovani A, Locati M . Macrophage activation and polarization. Front Biosci 2008; 13: 453–461.
Kass DJ, Yu G, Loh KS, Savir A, Borczuk A, Kahloon R et al. Cytokine-like factor 1 gene expression is enriched in idiopathic pulmonary fibrosis and drives the accumulation of CD4+ T cells in murine lungs: evidence for an antifibrotic role in bleomycin injury. Am J Pathol 2012; 180: 1963–1978.
Kissil JL, Walmsley MJ, Hanlon L, Haigis KM, Bender Kim CF, Sweet-Cordero A et al. Requirement for Rac1 in a K-ras induced lung cancer in the mouse. Cancer Res 2007; 67: 8089–8094.
Shaw AT, Meissner A, Dowdle JA, Crowley D, Magendantz M, Ouyang C et al. Sprouty-2 regulates oncogenic K-ras in lung development and tumorigenesis. Genes Dev 2007; 21: 694–707.
Cabrita MA, Christofori G . Sprouty proteins, masterminds of receptor tyrosine kinase signaling. Angiogenesis 2008; 11: 53–62.
Yusoff P, Lao DH, Ong SH, Wong ES, Lim J, Lo TL et al. Sprouty2 inhibits the Ras/MAP kinase pathway by inhibiting the activation of Raf. J Biol Chem 2002; 277: 3195–3201.
Elsum IA, Martin C, Humbert PO . Scribble regulates an EMT-polarity pathway through modulation of MAPK-ERK signaling to mediate junction formation. J Cell Sci 2013; 126: 3990–3999.
Nagasaka K, Pim D, Massimi P, Thomas M, Tomaic V, Subbaiah VK et al. The cell polarity regulator hScrib controls ERK activation through a KIM site-dependent interaction. Oncogene 2010; 29: 5311–5321.
McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EW, Chang F et al. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta 2007; 17738: 1263–1284.
Karreth FA, Tuveson DA . Modelling oncogenic Ras/Raf signalling in the mouse. Curr Opin Genet Dev 2009; 19: 4–11.
Roberts PJ, Der CJ . Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 2007; 26: 3291–3310.
Dhillon AS, Hagan S, Rath O, Kolch W . MAP kinase signalling pathways in cancer. Oncogene 2007; 26: 3279–3290.
Borrello MG, Degl'Innocenti D, Pierotti MA . Inflammation and cancer: the oncogene-driven connection. Cancer Lett 2008; 267: 262–270.
Funaba M, Zimmerman CM, Mathews LS . Modulation of Smad2-mediated signaling by extracellular signal-regulated kinase. J Biol Chem 2002; 277: 41361–41368.
Sparmann A, Bar-Sagi D . Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 2004; 6: 447–458.
Hanahan D, Weinberg RA . Hallmarks of cancer: the next generation. Cell 2011; 144: 646–674.
Lewis CE, Pollard JW . Distinct role of macrophages in different tumor microenvironments. Cancer Res 2006; 66: 605–612.
Cullinane C, Dorow DS, Jackson S, Solomon B, Bogatyreva E, Binns D et al. Differential (18)F-FDG and 3'-deoxy-3'-(18)F-fluorothymidine PET responses to pharmacologic inhibition of the c-MET receptor in preclinical tumor models. J Nucl Med 2011; 52: 1261–1267.
Acknowledgements
We thank Dr Jason Li, Dr David Bimms, Sam Williams, Olivia Cakebread, Tanja Kinwel and the microscopy and histology core at the Peter MacCallum Cancer Centre. We also thank Dr Alison Dooley and Prof Roderick Bronson from the Massachusetts Institute of Technology for their technical advice and to Drs Helena Richardson and Sarah Russell for critical reading of the manuscript. This study was supported by grants from the NHMRC of Australia (no. 1025239 for TJP and RJO; no. 1004434 for IAE and LLY), Movember/PCFA and Richard Pratt Foundation (for HBP). IAE was supported by a Cancer Council Victoria Postgraduate Research Scholarship and POH was supported by a Biomedical Career Development Award from the NHMRC of Australia.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Oncogene website
Supplementary information
Rights and permissions
About this article
Cite this article
Elsum, I., Yates, L., Pearson, H. et al. Scrib heterozygosity predisposes to lung cancer and cooperates with KRas hyperactivation to accelerate lung cancer progression in vivo. Oncogene 33, 5523–5533 (2014). https://doi.org/10.1038/onc.2013.498
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2013.498
Keywords
This article is cited by
-
Apical–basal polarity and the control of epithelial form and function
Nature Reviews Molecular Cell Biology (2022)
-
Afadin couples RAS GTPases to the polarity rheostat Scribble
Nature Communications (2022)
-
The Scribble family in cancer: twentieth anniversary
Oncogene (2020)
-
Emerging roles for LPP in metastatic cancer progression
Journal of Cell Communication and Signaling (2018)
-
An interaction between Scribble and the NADPH oxidase complex controls M1 macrophage polarization and function
Nature Cell Biology (2016)